Adtalem Global Education is Tuesday's IBD Stock Of The Day as the leading provider of health care education, which has bet on ...

GeneDx is Monday's IBD Stock Of The Day. Shares of the DNA-reading player are eyeing multiple buy points on a massive gain.

How to protect against high-pressure marketing tactics.

Nvidia is IBD Stock Of The Day as the AI chipmaker rises above its 50-day moving average and a downward-sloping trendline.

Sanofi stock rose nearly 7% ... Both UC and CD indications are primary forms of IBD, marked by chronic inflammation in the gastrointestinal tract. In recent years, there has been a surge in ...

Teva Pharmaceutical (NYSE: TEVA) and Sanofi (NASDAQ: SNY) stocks were rising on Tuesday after the companies announced successful results of a phase 2 study involving the treatment of patients with ...

The duo has planned a Phase 3 program for the drug in IBD, subject to regulatory feedback. “The results from the RELIEVE UCCD study have exceeded our expectations, and I am deeply moved by the ...

PFE issues its financial guidance for 2025. MRK and ABBV announce M&A deals. SNY/TEVA's IBD drug succeeds in a phase IIb ...

Dow, S&P 500, and Nasdaq futures are rising in premarket trading on New Year's Eve as the stock market limps into 2025.

In a report released today, Sam Slutsky from LifeSci Capital maintained a Buy rating on Spyre Therapeutics (SYRE – Research Report), with a ...

Weʼre unable to load stories right now.